# MK Venture Capital

> MK Venture Capital is a VC fund backing Therapeutics and Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Muenchen, Germany
- Total investments: 1
- Last investment: Jul 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mk-venture-capital-gmbh
- X (Twitter): https://twitter.com/@MKVentureCap
- Website: https://mk-vc.com
- Facebook: https://www.facebook.com/MK-Venture-Capital-GmbH-690669627760479

MK Venture Capital is a VC fund in Muenchen focused on Therapeutics and Biotechnology. MK Venture Capital makes investing in promising startups easy and low-risk.

## Contacts

5 contacts available for MK Venture Capital. Shizune tracks 1 team members at MK Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mk-venture-capital-gmbh?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Mato M. Krahl | Managing Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Reapplix | Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark. | $22.9M | Series A | Jul 13, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [Lauxera Capital Partners](https://shizune.co/investors/profile/lauxera-capital-partners) — VC Fund, 1 deal together
- [North-East Healthcare Investment](https://shizune.co/investors/profile/north-east-healthcare-investment) — VC Fund, 1 deal together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 1 deal together
- [VF Venture](https://shizune.co/investors/profile/vf-venture) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does MK Venture Capital invest in?

MK Venture Capital invests primarily in Therapeutics, Biotechnology and Medical Device startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact MK Venture Capital?

Public channels for MK Venture Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at MK Venture Capital?

The team at MK Venture Capital includes Mato M. Krahl (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co